insiderdelta
CoverageForm 410-K10-Q8-K13D13G13F

CI · Cigna Group - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · CI

1Y3Y5YMax
Sign in to download
AnnualQuarterly

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$274.90B$247.12B$195.26B$180.52B$174.08B$160.40B
Cost of Revenue$214.99B$182.51B$133.80B$124.83B$117.55B$103.48B
Gross Profit$59.91B$64.61B$61.46B$55.68B$56.52B$56.92B
R&D------
SG&A$14.62B$14.84B$14.82B$13.19B$13.03B$14.07B
Total Operating Expenses------
D&A$2.77B$2.77B$3.04B$2.94B$2.92B$2.80B
Operating Income$9.20B$9.42B$8.54B$8.41B$7.93B$8.15B
Interest Expense$1.40B$1.50B$1.40B$1.30B$1.30B$1.40B
Income Tax$1.49B$1.49B$141.00M$1.61B$1.37B$2.38B
Net Income$3.43B$3.43B$5.16B$6.67B$5.37B$8.46B
EPS - Basic$22.33$12.25$17.57$21.54$15.87$23.17
EPS - Diluted$22.18$12.12$17.39$21.30$15.73$22.96

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$7.68B$7.55B$7.82B$5.92B$5.08B$10.18B
Accounts Receivable$28.77B$24.23B$17.72B$17.22B$15.07B$12.19B
Inventory$7.34B$6.69B$5.64B$4.78B$3.72B$3.17B
Accounts Payable$10.66B$9.29B$8.55B$7.78B$6.66B$5.48B
Current Assets$47.81B$48.87B$37.35B$30.12B$36.13B$27.80B
Total Assets$157.92B$155.88B$152.76B$143.93B$154.89B$155.45B
Current Liabilities$56.34B$57.98B$48.72B$41.23B$43.57B$36.02B
Long-term Debt------
Total Liabilities$116.05B$114.64B$106.41B$98.98B$107.70B$105.06B
Stockholders' Equity$41.71B$41.03B$46.22B$44.87B$47.11B$50.32B
Retained Earnings$47.87B$43.52B$41.65B$37.87B$32.59B$28.57B

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$9.60B$10.36B$11.81B$8.66B$7.19B$10.35B
Investing Cash Flow($4.41B)($2.10B)($5.17B)$3.10B($3.61B)$2.98B
Financing Cash Flow($6.42B)($7.65B)($4.29B)($11.24B)($8.21B)($8.53B)
CapEx------
Free Cash Flow------

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin21.8%26.1%31.5%30.8%32.5%35.5%
Operating margin3.3%3.8%4.4%4.7%4.6%5.1%
EBITDA margin4.4%4.9%5.9%6.3%6.2%6.8%
Net margin1.2%1.4%2.6%3.7%3.1%5.3%
Free cash flow margin------
FCF / Net income------
R&D / Revenue------
SG&A / Revenue5.3%6.0%7.6%7.3%7.5%8.8%
Effective tax rate30.3%30.3%2.7%19.4%20.3%22.0%
Return on assets2.2%2.2%3.4%4.6%3.5%5.4%
Return on equity8.2%8.4%11.2%14.9%11.4%16.8%
Return on invested capital------
Liquidity
Current ratio0.850.840.770.730.830.77
Quick ratio0.720.730.650.610.740.68
Cash ratio0.140.130.160.140.120.28
Leverage
Debt / Equity------
Debt / Assets------
Debt / EBITDA------
Interest coverage6.6x6.3x6.1x6.5x6.1x5.8x
Equity multiplier3.793.803.303.213.293.09
Liabilities / Assets0.730.740.700.690.700.68
Efficiency
Asset turnover1.741.591.281.251.121.03
Inventory turnover29.3027.2723.7026.1331.5832.70
Days sales outstanding38d36d33d35d32d28d
Days inventory outstanding12d13d15d14d12d11d
Days payable outstanding18d19d23d23d21d19d
Cash conversion cycle33d31d25d26d22d20d
Valuation
P / E12.4x22.8x17.2x15.6x14.6x9.1x
P / B1.8x1.9x1.9x2.3x1.7x1.5x
P / S0.3x0.3x0.5x0.6x0.4x0.5x
EV / EBITDA5.5x5.8x7.0x8.6x6.7x6.1x
Growth
Revenue growth (YoY)11.2%26.6%8.2%3.7%8.5%4.5%
Revenue CAGR (3y)15.0%12.4%6.8%5.5%63.5%-
Revenue CAGR (5y)11.4%10.0%37.4%---
Gross profit growth (YoY)-7.3%5.1%10.4%-1.5%-0.7%1.8%
Operating income growth (YoY)-2.3%10.3%1.4%6.0%-2.7%0.9%
Net income growth (YoY)0.0%-33.5%-22.6%24.3%-36.6%65.7%
EPS growth (YoY)83.0%-30.3%-18.4%35.4%-31.5%70.8%
EPS CAGR (3y)1.4%-8.3%-8.8%16.6%29.8%-
EPS CAGR (5y)-0.7%-2.0%19.3%---
FCF growth (YoY)------
FCF CAGR (5y)------
Book value growth (YoY)1.7%-11.2%3.0%-4.8%-6.4%11.0%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$283.04B total
Evernorth$234.95B · 83.0%
Cigna Healthcare$47.41B · 16.8%
All Other Segments$674.00M · 0.2%

Product / service

$469.10B total
Product$216.67B · 46.2%
Network Pharmacy$125.57B · 26.8%
Home Delivery And Specialty$80.49B · 17.2%
Service$16.92B · 3.6%
Service Fees And Other Revenues$15.42B · 3.3%
Other Pharmacy$13.33B · 2.8%
Service Other$696.00M · 0.1%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

2.29
Grey zone

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

6/9
Neutral
  • ✓Net income positive
  • ✓Operating cash flow positive
  • ✗ROA improved YoY
  • ✓Cash flow > net income
  • -Long-term debt decreased
  • ✓Current ratio improved
  • ✓No share dilution
  • ✗Gross margin improved
  • ✓Asset turnover improved

Peer comparison

Same SIC group: Hospital & Medical Service Plans

CompanyRevenue (last FY)Net marginROE
UNH$447.57B2.7%12.0%
TRUP$1.44B1.4%5.1%
CNC$194.78B-3.4%-33.4%
ALHC$3.95B-0.0%-0.4%
CLOV$1.92B-4.4%-27.7%

Comparing Cigna Group against the 5 most active filers in the same SIC group.

Dividends

$4.58/share trailing 12 months · -21.3% YoY

Ex-datePer share
Mar 5, 2026$1.5600
Dec 4, 2025$1.5100
Sep 4, 2025$1.5100
Jun 3, 2025$1.5100
Mar 5, 2025$1.5100
Dec 4, 2024$1.4000
Sep 4, 2024$1.4000
Jun 4, 2024$1.4000
Mar 5, 2024$1.4000
Dec 5, 2023$1.2300
Sep 5, 2023$1.2300
Jun 6, 2023$1.2300
Mar 7, 2023$1.2300
Dec 5, 2022$1.1200
Sep 6, 2022$1.1200
Jun 7, 2022$1.1200
Mar 8, 2022$1.1200
Dec 6, 2021$1.0000
Sep 7, 2021$1.0000
Jun 7, 2021$1.0000
Mar 9, 2021$1.0000
Mar 9, 2020$0.0400
Mar 8, 2019$0.0400
Mar 9, 2018$0.0400